特拉布
医学
格雷夫斯病
甲状腺炎
甲状腺
甲状腺球蛋白
甲状腺过氧化物酶
免疫学
自身免疫性疾病
Graves眼病
抗体
内科学
作者
Yushu Li,Zhongyan Shan
出处
期刊:Intern J Endocrinol Metab
日期:2012-05-20
卷期号:32 (03): 155-158
被引量:1
标识
DOI:10.3760/cma.j.issn.1673-4157.2012.03.003
摘要
Autoimmune thyroid diseases (AITD) are a group of diseases with significant different clinical manifestation,but with similar genetic and immunologic background.Thyrotropin receptor antibody (TRAb) has significance in the diagnosis and prediction of prognosis for Graves' disease (GD) and Graves'ophthalmopathy (GO).Anti-thyroperoxidase antibody (TPOAb) and anti-thyroglobulin antibody are hallmark of autoimmune thyroiditis (AIT).The therapies for GD are mainly to control the hyperthyroidism.Immunosuppressive therapy is used for sever GO.Up to date,evidence-based medical evidence has demonstrated that treatment using selenium could decrease the level of TPOAb in the patients with AIT.The immune therapies to the pathogenesis of AITD still need to be developed and supported by clinical evidence.
Key words:
Autoimmune (thyroid) diseases ; Graves' disease; Graves' ophthalmopathy; Autoimmune thyroiditis
科研通智能强力驱动
Strongly Powered by AbleSci AI